Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RotaTeq concomitant use with meningococcal group C conjugate vaccine in healthy infants
2006-005445-11Phase 3Completed
- Sponsor
- Sanofi Pasteur MSD S.N.C.
- Start
- Nov 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of rotavirus vaccine, live, oral, pentavalent and Meningococcal C-CRM conjugate vaccine in rotaviral diarrhea and meningococcal disease (2 arms), sponsored by Sanofi Pasteur MSD S.N.C. Started Nov 2006; status: completed.
02
Drugs
rotavirus vaccine, live, oral, pentavalentMeningococcal C-CRM conjugate vaccine
03
Conditions
rotaviral diarrheameningococcal disease
Beyond the preview
Go deeper on 2006-005445-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005445-11.